Prihlásiť sa Zaregistrujte sa zadarmo

Výnos na zamestnanca spoločnosti Cotinga Pharmaceuticals

Aká je hodnota metriky Výnos na zamestnanca spoločnosti Cotinga Pharmaceuticals?

Hodnota metriky Výnos na zamestnanca spoločnosti Cotinga Pharmaceuticals, Inc. je N/A

Aká je definícia metriky Výnos na zamestnanca?

Výnosy na zamestnanca (Revenue per employee - RPE) je výnos spoločnosti vydelený počtom zamestancov.

Čomu sa venuje spoločnosť Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.